When stabilized, β-catenin translocates into the nucleus, where it collaborates with the LEF/TCF transcriptional activators, leading to the binding and activation of downstream gene targets related to cancer stem cells, including c-Myc, Oct-4, Sox-2, and Nanog. The gene discussed is MYC; the disease is cancer.